Hiroyuki Hata

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide

Yawara Kawano, Shiho Fujiwara, Naoko Wada et al. · International Journal of Oncology · 2012 · 115 citations · Full text

Medicine, Cell Biology, Hematology +16

The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach

Hiroo Katsuya, Saiful Islam, Benjy J.Y. Tan et al. · Cell Reports · 2019 · 94 citations · Full text

Life Sciences, Biology, Molecular Biology +13

<i>Mycobacterium kumamotonense</i> Sp. Nov. Recovered from Clinical Specimen and the First Isolation Report of <i>Mycobacterium arupense</i> in Japan: Novel Slowly Growing, Nonchromogenic Clinical Isolates Related to <i>Mycobacterium terrae</i> Complex

Takayuki Masaki, Kiyofumi Ohkusu, Hiroyuki Hata et al. · Microbiology and Immunology · 2006 · 87 citations

Life Sciences, Biology, Microbiology +17

Macrophage inflammatory protein‐1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM

Shima Uneda, Hiroyuki Hata, Fumihiko Matsuno et al. · British Journal of Haematology · 2002 · 85 citations · Full text

Medicine, Immunology, Pathology +16